OTCM
BLBRF
Dec 26, Last price
0.17
Name
Bloomberry Resorts Corp
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
30.72%
Rev. 5Y
36.45%
Div Yld LY
—
Div Yld TTM
—
Revenues
312k
-33.81%
Net income
-2m
L+44.92%
CFO
-1m
L+55.87%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Blueberries Medical Corp. conducts comprehensive operations in Colombia, covering the entire process of medicinal cannabis and its derivative products—from their initial cultivation and development to final production and distribution. The company specializes in providing pharmaceutical-grade cannabis oil extracts along with other associated therapeutic products. Its corporate headquarters are situated in Bogotá, Colombia.
Key people
Chairman of the Board, Chief Executive Officer · since 2013
Vice Chairman of the Board · since 2011
Xingyu Chen
Senior Vice President, Chief Financial Officer · since 2012
Theunis D. Van Niekerk
Senior Vice President, Construction · since 2017
Cyrus Sherafat
Senior Vice President for Casino Marketing · since 2014
Laurence Upton
Senior Vice President for International Marketing · since 2014
Compliance Officer, Corporate Secretary · since 2015
Estella Tuason-Occena
Chief Financial Officer, Treasurer · since 2015
Jonas S. Khaw
Assistant Corporate Secretary · since 2015
Donato C. Almeda
Director · since 2011
Thomas Arasi
President, Chief Operating Officer, Director · since 2013
Director · since 2011
Independent Director · since 2011
Jose P. Perez
Independent Director · since 2019
Valuation
Title PHP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||